Breaking News
Anna Protopapas
About Anna Protopapas
Ms. Protopapas joined Mersana in March 2015, bringing a substantial track record of executive leadership and business experience in the biotech industry. Prior to Mersana, Ms. Protopapas was President of Millennium, where she led Takeda Pharmaceutical Co.’s $1.3 billion oncology business. Ms. Protopapas also served as the Executive Vice President of Global Business Development for Takeda Pharmaceuticals where she was responsible for global acquisitions, partnering, licensing and venture investing. In this role, she led Takeda’s $12 billion acquisition of Nycomed, a critical step in the company’s globalization. Ms. Protopapas was a member of Takeda’s executive committee and was elected a corporate officer in 2011. Earlier, Ms. Protopapas was an executive officer at Millennium Pharmaceuticals and served in various senior leadership positions, playing an integral role in the company’s transformation from a genomics start-up to a fully integrated oncology leader. She was instrumental in the sale of Millennium to Takeda for $8.8 billion.
Ms. Protopapas served on the Board of Directors of Ariad Pharmaceuticals and chaired the compensation committee, from May 2015 until the sale of the company to Takeda for $5.2 billion in January 2017. Ms Protopapas also served on the Board of Directors of Bioverativ from February 2017 until the sale of the company to Sanofi for $11.6 billion in February 2018.
Ms. Protopapas is married to Tom Kinney, has three children; Nikolas, Sofia and Eleni and resides in Boston’s South End neighborhood. She grew up in Cyprus and visits the island often.